Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03557385Phase 4Completed

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

Role: collaborator

NCT05007535Unknown

Tissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular Ultrasound

Role: collaborator

NCT05079906Not ApplicableWithdrawn

Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® Catheter

Role: lead

NCT02060682Completed

Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical Practice

Role: lead

NCT03052803Completed

Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries

Role: collaborator

NCT02577484Unknown

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Role: lead

NCT01406236Not ApplicableTerminated

SAFE-PCI for Women

Role: collaborator

All 7 trials loaded